Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis.

Vuckovic, Biljana A; Djeric, Mirjana J; Tomic, Branko V; Djordjevic, Valentina J; Bajkin, Branislav V; Mitic, Gorana P

Vuckovic, Biljana A; Djeric, Mirjana J; Tomic, Branko V; Djordjevic, Valentina J; Bajkin, Branislav V; Mitic, Gorana P.

Afiliación

Vuckovic BA; Faculty of Medicine, Center of Laboratory Medicine, University of Novi Sad, Novi Sad.
Djeric MJ; Faculty of Medicine, Center of Laboratory Medicine, University of Novi Sad, Novi Sad.
Tomic BV; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade.
Djordjevic VJ; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade.
Bajkin BV; Dental Clinic of Vojvodina, Faculty of Medicine Novi Sad, University of Novi Sad, Novi Sad, Serbia.
Mitic GP; Faculty of Medicine, Center of Laboratory Medicine, University of Novi Sad, Novi Sad.

Blood Coagul Fibrinolysis ; 29(1): 19-24, 2018 Jan.

Article en En | MEDLINE | ID: mdl-28777103

Asunto(s)

Inhibidor 1 de Activador Plasminogénico/genética; Trombosis de la Vena/genética; Adulto; Anciano; Anciano de 80 o más Años; Estudios de Casos y Controles; Femenino; Fibrinólisis; Predisposición Genética a la Enfermedad; Humanos; Masculino; Persona de Mediana Edad; Polimorfismo Genético; Trombosis de la Vena/sangre; Trombosis de la Vena/patología; Adulto Joven

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidor 1 de Activador Plasminogénico / Trombosis de la Vena Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google